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Dear Editor,
We have read the recent article by Sniezawska and colleagues
with great interest.1 The authors investigated the frequency of
polymorphism in the MTHFR (C677T), MTR (A2756G), and MTHFD1
(G1958A) genes and analysed the levels of homocysteine (Hcy),
methionine, asymmetric dimethylarginine (ADMA), and arginine
in epileptic patients treated with various antiepileptic drugs
(AEDs). They found that AED pharmacotherapy in epileptic
patients increases Hcy and ADMA levels. These authors suggested
that their study showed an increase in Hcy level accompanied by
an increase in ADMA level in epileptic patients receiving AEDs and
concluded that hyperhomocysteinemia (HHcy) disrupts the
feedback control of Hcy over ADMA.
In the discussion, the authors cite Jonasson et al.2 and Wanby
et al.3 who showed that patients with vascular disease undergoing
long-term AED therapy experience HHcy, but the concentration of
ADMA does not always increase. Unfortunately these authors did
not study Hcy and ADMA levels during the long-term AED therapy.
Elevated ADMA levels were ﬁrst demonstrated in AED-treated
epileptic patients in 2009.4 In this study, the authors investigated
the effect of valproic acid (VPA) and carbamazepine (CBZ)
monotherapies on plasma levels of ADMA and Hcy and serum
levels of folate and vitamin B12 in newly diagnosed epileptic
patients. They found that ADMA levels signiﬁcantly increased after
the treatment in both VPA and CBZ groups. Homocysteine levels
also increased in both the treatment groups, but the difference was
signiﬁcant only in the VPA group. The correlation between the
changes in the ADMA and homocysteine levels was insigniﬁcant.
Similarly, the difference between the mean ADMA change and
mean homocysteine change was insigniﬁcant. Thus, these results
showed that ADMA plasma levels were not associated with the
harmonic changes in homocysteine.1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.12.006Surprisingly, Sniezawska et al.1 did not cite this article in their
study. In our opinion, the lack of discussion of the results of this
study may leave readers with an incomplete understanding of the
issue. We must consider whether increased ADMA after AED
treatment is independent of the changes in plasma Hcy.
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